Aditya Birla Sun Life AMC Ltd (ABSLAMC) Q1 FY27 Results Analysis: Margin Compresses 428 bps, Employee Costs Surge 26%
Cofacto Research
Updated July 21, 2026
2 min read
Negative
Aditya Birla Sun Life AMC Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 462.96 Cr (+3.48% YoY) and PAT growth of +11.68% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 21, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 462.96 Cr (+3.48% YoY) |
|---|
| PAT (Q1) | Rs. 309.49 Cr (+11.68% YoY) |
|---|
| EBITDA margin | 55.66% (-378 bps YoY) |
|---|
| EPS (Q1) | Rs. 10.72 (+11.67% YoY) |
|---|
| Market cap | Rs. 30,159.62 Cr |
|---|
| CMP | Rs. 1,043.10 |
|---|
Quarter Snapshot
Revenue grew modestly 3.48% YoY but operating profit declined 4.26% as employee costs surged 25.59% YoY, compressing operating margins by 428 bps to 52.88%. PAT grew 11.68% YoY only due to a non-recurring MTM gain of Rs.162 Cr, masking underlying weakness. Regulatory yield compression from SEBI circular and elevated cost structure pose near-term headwinds.
Key Investment Insights
Key Positives
- Revenue from operations grew 3.48% YoY to Rs.462.96 Cr (consolidated).
- PAT grew 11.68% YoY to Rs.309.49 Cr, driven by a Rs.162 Cr MTM gain.
- Other expenses declined 2.23% YoY to Rs.73.63 Cr, indicating cost rationalization.
Risk Factors
- Operating profit declined 4.26% YoY and 3.41% QoQ.
- Operating margin compressed 428 bps YoY to 52.88%, the third consecutive quarterly decline.
- Employee expenses surged 25.59% YoY, significantly outpacing revenue growth of 3.48%.
- Revenue yield compression from SEBI circular (3–4 bps impact) is materializing.
- PAT quality is low due to reliance on volatile MTM gains; normalized PAT is estimated at Rs.225–240 Cr vs reported Rs.309.49 Cr.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now